Health

Valneva, Ema’s green light case for vaccine takes shape in late March

ADVERTISING
Rome, March 1 – The European green light for the Valneva Covid vaccine could reach the end of March. This was announced by the French company itself, after the Committee for Medicinal Products for Human Use (CHMP) of Ema provided an initial assessment for VLA2001 (this is the name of the candidate Valneva vaccine) by submitting a list of questions to the company. The French company expects to be able to respond within the next few days.

ADVERTISING

ADVERTISING
1 of 6